Effectiveness of a Lifestyle Intervention for Pregnant Women With Abnormal Glucose Metabolism in Early Pregnancy: EAGM Trial

NCT06767722 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3430

Last updated 2025-07-01

No results posted yet for this study

Summary

This is a multicentre, parallel-group, open-label, pragmatic, randomised-control trial of early lifestyle intervention versus routine prenatal care by random allocation (1:1) in women with early abnormal glucose metabolism (EAGM) to compare the incidence of large-gestational age and preterm birth between two groups. The investigators aim to assess the effectiveness of early lifestyle interventions and to provide evidence for the optimal standard management for Chinese women with EAGM.

Conditions

  • Early Pregnancy
  • Fasting Plasma Glucose
  • Hemoglobin A1c Protein, Human
  • Lifestyle Intervention
  • Adverse Pregnancy Outcomes

Interventions

BEHAVIORAL

Lifestyle intervention and self-monitoring of blood glucose

The intervention will consist of a lifestyle intervention that comprises advice on diet, exercise, weight management, and self-monitoring of blood glucose (SMBG) with feedback from healthcare professionals on results and insulin treatment if indicated.

Sponsors & Collaborators

  • First People's Hospital of Foshan

    collaborator OTHER
  • Jiangmen Maternity and Child Health Care Hospital

    collaborator UNKNOWN
  • Panyu Maternal And Child Care Service Centre Of Guangzhou

    collaborator UNKNOWN
  • The Affiliated Shunde Hospital of Jinan University

    collaborator UNKNOWN
  • Shenzhen Second People's Hospital

    collaborator OTHER
  • Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University

    collaborator UNKNOWN
  • BoAi Hospital of Zhongshan

    collaborator OTHER
  • Yuebei People's Hospital

    collaborator OTHER
  • Qingyuan People's Hospital

    collaborator OTHER
  • The Sixth Affliated Hospital of Jinan University

    collaborator UNKNOWN
  • Baoan Maternal And Child Health Care Hospital, Shenzhen, China

    collaborator UNKNOWN
  • Jiangxi Maternal and Child Health Hospital

    collaborator OTHER
  • Guangxi provincial maternal and chidren's hospital

    collaborator UNKNOWN
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Obstetrics and Gynecology Hospital of Zhejiang University

    collaborator UNKNOWN
  • Xiangya Hospital of Central South University

    collaborator OTHER
  • Guangzhou Women's and Children's Hospital

    collaborator UNKNOWN
  • First Affiliated Hospital, Sun Yat-Sen University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-16
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06767722 on ClinicalTrials.gov